Shopping Cart 0
Cart Subtotal
USD 0

Medical University of South Carolina - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Medical University of South Carolina (MUSC) is a healthcare university that provides learning and discovery opportunities for health care professionals and biomedical scientists. The university conducts research on health sciences, and offers comprehensive healthcare services. It provides treatments for ailments including neurosciences, cardiology, diabetes, endocrinology and medical genetics, infectious disease, nephrology, anesthesia and perioperative medicine, obstetrics and gynecology, dermatology, pulmonary and critical care, and urology. MUSC also provides educational programs in the areas of dental medicine, graduate studies, health professions, medicine, nursing and pharmacy. The university operates through a network of colleges. It also operates through medical service centers, cancer care center, vascular center, and institutes in different parts of the US. MUSC is headquartered in Charleston, South Carolina, the US.

Medical University of South Carolina-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Medical University of South Carolina, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Medical University of South Carolina, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Medical University of South Carolina, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Medical University of South Carolina, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Medical University of South Carolina, Medical Devices Deals, 2012 to YTD 2018 9

Medical University of South Carolina, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Medical University of South Carolina, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Bristol-Myers Squibb Enters into Research Agreement with Medical University of South Carolina 11

Berg To Enter Into Agreement With Medical University Of South Carolina For Lupus Biomarker Discovery 12

iBio Amends Agreement with Medical University of South Carolina 13

Licensing Agreements 14

CharlestonPharma Enters into Licensing Agreement with Medical University of South Carolina 14

CharlestonPharma Enters into Licensing Agreement with Medical University of South Carolina 15

Medical University of South Carolina-Key Competitors 16

Medical University of South Carolina-Key Employees 17

Medical University of South Carolina-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Recent Developments 19

Government and Public Interest 19

Jul 24, 2018: Parkinson's Foundation designates three centers of excellence in parkinson's care 19

Dec 07, 2017: Teamwork makes heart procedures less invasive, reduces recovery time 20

Nov 16, 2017: MUSC leads research on potential lupus treatment 22

May 17, 2017: Antibody that neutralizes sMIC boosts CTLA4 immunotherapy response and reduces colitis 24

May 09, 2017: Colorectal tumors initiate VEGF-A/CXCL1 cascade, creating distant niches for metastases 26

Apr 06, 2017: Stem cell drug screen yields potential alternative to statins 27

Mar 13, 2017: A novel protein regulates cancer immunity and could offer a therapeutic target 28

Jan 11, 2017: A novel cancer immunotherapy shows early promise in preclinical studies 29

Product News 30

May 16, 2018: Novel therapy inhibits complement to preserve neurons and reduce inflammation after stroke 30

Jan 26, 2018: Pyridostigmine treatment reverses pediatric complications of botulinum toxin therapy 32

Other Significant Developments 34

Aug 15, 2018: 'BOOST-3' Trial Seeks to Improve Outcomes After Severe Traumatic Brain Injury 34

Jun 14, 2017: Johnson & Johnson Medical Devices Companies Bring Real-World Evidence to Infection Risk Management to Help Medical University of South Carolina Reduce Infection Risk in the OR 36

Appendix 37

Methodology 37

About GlobalData 37

Contact Us 37

Disclaimer 37


List Of Figure

List of Figures

Medical University of South Carolina, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Medical University of South Carolina, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Medical University of South Carolina, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Medical University of South Carolina, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Medical University of South Carolina, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Medical University of South Carolina, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Medical University of South Carolina, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Medical University of South Carolina, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Medical University of South Carolina, Pharmaceuticals & Healthcare, Key Facts 2

Medical University of South Carolina, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Medical University of South Carolina, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Medical University of South Carolina, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Medical University of South Carolina, Deals By Therapy Area, 2012 to YTD 2018 8

Medical University of South Carolina, Medical Devices Deals, 2012 to YTD 2018 9

Medical University of South Carolina, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Bristol-Myers Squibb Enters into Research Agreement with Medical University of South Carolina 11

Berg To Enter Into Agreement With Medical University Of South Carolina For Lupus Biomarker Discovery 12

iBio Amends Agreement with Medical University of South Carolina 13

CharlestonPharma Enters into Licensing Agreement with Medical University of South Carolina 14

CharlestonPharma Enters into Licensing Agreement with Medical University of South Carolina 15

Medical University of South Carolina, Key Competitors 16

Medical University of South Carolina, Key Employees 17

Medical University of South Carolina, Subsidiaries 18

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Medical University of South Carolina, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.